129 related articles for article (PubMed ID: 11119626)
1. Properties of wild-type, C-terminally truncated, and chimeric maedi-visna virus glycoprotein and putative pseudotyping of retroviral vector particles.
Zeilfelder U; Bosch V
J Virol; 2001 Jan; 75(1):548-55. PubMed ID: 11119626
[TBL] [Abstract][Full Text] [Related]
2. Maedi-visna virus and its relationship to human immunodeficiency virus.
Thormar H
AIDS Rev; 2005; 7(4):233-45. PubMed ID: 16425963
[TBL] [Abstract][Full Text] [Related]
3. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
Celma CC; Paladino MG; González SA; Affranchino JL
Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
[TBL] [Abstract][Full Text] [Related]
4. Visna/maedi virus Env protein expressed by a vaccinia virus recombinant induces cell-to-cell fusion in cells of different origins in the apparent absence of Env cleavage: role of glycosylation and of proteoglycans.
Sánchez AB; Rodríguez D; Garzón A; Amorena B; Esteban M; Rodríguez JR
Arch Virol; 2002 Dec; 147(12):2377-92. PubMed ID: 12491104
[TBL] [Abstract][Full Text] [Related]
5. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
[TBL] [Abstract][Full Text] [Related]
6. Expression of the gp150 maedi visna virus envelope precursor protein by mammalian expression vectors.
Fraisier C; Arnarson H; Barbezange C; Andrésdŏttir V; Carrozza ML; De Andrés D; Tolari F; Rosati S; Luján L; Pépin M; Amorena B; Harkiss G; Blacklaws B; Suzan-Monti M
J Virol Methods; 2007 Dec; 146(1-2):363-7. PubMed ID: 17675253
[TBL] [Abstract][Full Text] [Related]
7. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
Affranchino JL; González SA
Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
[TBL] [Abstract][Full Text] [Related]
8. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
[TBL] [Abstract][Full Text] [Related]
9. Development of transgenic sheep that express the visna virus envelope gene.
Clements JE; Wall RJ; Narayan O; Hauer D; Schoborg R; Sheffer D; Powell A; Carruth LM; Zink MC; Rexroad CE
Virology; 1994 May; 200(2):370-80. PubMed ID: 8178428
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
11. Functional murine leukemia virus vectors pseudotyped with the visna virus envelope show expanded visna virus cell tropism.
Bruett L; Clements JE
J Virol; 2001 Dec; 75(23):11464-73. PubMed ID: 11689628
[TBL] [Abstract][Full Text] [Related]
12. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein.
Spies CP; Compans RW
Virology; 1994 Aug; 203(1):8-19. PubMed ID: 8030287
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
14. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
15. Serum containing ovine IgG2 antibody specific for maedi visna virus envelope glycoprotein mediates antibody dependent cellular cytotoxicity.
Singh I; McConnell I; Dalziel R; Blacklaws BA
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):357-66. PubMed ID: 16876878
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infection.
González B; Reina R; García I; Andrés S; Glaria I; Alzueta M; Mora MI; Jugo BM; Arrieta-Aguirre I; de la Lastra JM; Rodríguez D; Rodríguez JR; Esteban M; Grilló MJ; Blacklaws BA; Harkiss GD; Chebloune Y; Luján L; de Andrés D; Amorena B
Vaccine; 2005 Jul; 23(34):4342-52. PubMed ID: 16005743
[TBL] [Abstract][Full Text] [Related]
17. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain.
Ritter GD; Mulligan MJ; Lydy SL; Compans RW
Virology; 1993 Nov; 197(1):255-64. PubMed ID: 8212561
[TBL] [Abstract][Full Text] [Related]
18. Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.
Blot V; Delamarre L; Perugi F; Pham D; Bénichou S; Benarous R; Hanada T; Chishti AH; Dokhélar MC; Pique C
J Cell Sci; 2004 Aug; 117(Pt 17):3983-93. PubMed ID: 15286176
[TBL] [Abstract][Full Text] [Related]
19. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein.
Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473
[TBL] [Abstract][Full Text] [Related]
20. Maedi-visna virus infection in sheep: a review.
Pépin M; Vitu C; Russo P; Mornex JF; Peterhans E
Vet Res; 1998; 29(3-4):341-67. PubMed ID: 9689746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
